EMEA-001870-PIP01-15-M02

Key facts

Active substance
Rimiducid
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0418/2019
PIP number
EMEA-001870-PIP01-15-M02
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of graft versus host disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Bellicum Pharma Ltd

Tel. +1 8323841100
E-mail: mansari@bellicum.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating